ConductScience.org, home

Paper34858740

Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes.

Kamolvisit S and 3 others. Cureus, 2021. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes. Papers, record 34858740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34858740

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes.
PubMed
Journal
Cureus
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.67
iCite
Revised in PubMed
2026-10-02
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kamolvisit SSarunporn
2Chirnaksorn SSupphamat
3Nimitphong HHataikarn
4Sungkanuparph SSomnuek

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130888594Pharmacological Treatment for Non-alcoholic Fatty Liver Disease.Adv Ther2019https://conductscience.org/library/papers/30888594PubMed
233069882Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus.Clin Gastroenterol Hepatol2022https://conductscience.org/library/papers/33069882PubMed
322326434Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.Gastroenterology2012https://conductscience.org/library/papers/22326434PubMed
430683625
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.
Lancet HIV2019https://conductscience.org/library/papers/30683625PubMed
530570529Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study.J Acquir Immune Defic Syndr2019https://conductscience.org/library/papers/30570529PubMed
611768834A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus.Clin Ther2001https://conductscience.org/library/papers/11768834PubMed
724673640Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time.Diabet Med2014https://conductscience.org/library/papers/24673640PubMed
830335697Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.Transplantation2019https://conductscience.org/library/papers/30335697PubMed
921618575Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.Hepatology2011https://conductscience.org/library/papers/21618575PubMed
1022435761Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.Liver Int2012https://conductscience.org/library/papers/22435761PubMed
1129223443Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes.Clin Gastroenterol Hepatol2018https://conductscience.org/library/papers/29223443PubMed
1215616246Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors.Diabetes Care2005https://conductscience.org/library/papers/15616246PubMed
1322879786Pioglitazone in the treatment of type 2 diabetes: safety and efficacy review.Clin Med Insights Endocrinol Diabetes2010https://conductscience.org/library/papers/22879786PubMed
1427621571Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?World J Gastroenterol2016https://conductscience.org/library/papers/27621571PubMed
1527322798Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.Ann Intern Med2016https://conductscience.org/library/papers/27322798PubMed
1629222911Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Hepatology2018https://conductscience.org/library/papers/29222911PubMed
1717135584A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.N Engl J Med2006https://conductscience.org/library/papers/17135584PubMed
1822760655Nonalcoholic fatty liver disease and HIV infection.Semin Liver Dis2012https://conductscience.org/library/papers/22760655PubMed
1927485838Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV.Curr HIV/AIDS Rep2016https://conductscience.org/library/papers/27485838PubMed
2028714183The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.Hepatology2018https://conductscience.org/library/papers/28714183PubMed

See all 29 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
41799137Virtual Screening of FDA-Approved Compounds: Exploring New Alternatives for HIV Treatment.ACS Omega2026https://conductscience.org/library/papers/41799137PubMed
40860752MAFLD: A Comprehensive Review of the Link Between Metabolic Dysfunction and Cardiovascular Risk.Hepat Med2025https://conductscience.org/library/papers/40860752PubMed
40397552Metabolic dysfunction-associated steatotic liver disease in people with HIV.Curr Opin HIV AIDS2025https://conductscience.org/library/papers/40397552PubMed
39552706Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer.Am J Prev Cardiol2024https://conductscience.org/library/papers/39552706PubMed
37745748Efficacy of SGLT2 Inhibitors Versus Pioglitazone in the Treatment of Non-alcoholic Fatty Liver Disease or Non-alcoholic Steatohepatitis: A Systematic Review.Cureus2023https://conductscience.org/library/papers/37745748PubMed
37280241Metabolic dysfunction-associated fatty liver disease in people living with HIV.Sci Rep2023https://conductscience.org/library/papers/37280241PubMed
37111209Nutritional and Lifestyle Therapy for NAFLD in People with HIV.Nutrients2023https://conductscience.org/library/papers/37111209PubMed
37065735Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37065735PubMed
36936142Effects of SGLT2 inhibitors on hepatic fibrosis and steatosis: A systematic review and meta-analysis.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/36936142PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
PPARG5468PubTator's text mininghttps://conductscience.org/library/genes/5468NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34858740

GET https://conductscience.org/api/papers/v1/34858740/references?page=2